A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
Authors
Keywords
-
Journal
LEUKEMIA
Volume 27, Issue 10, Pages 2056-2061
Publisher
Springer Nature
Online
2013-06-07
DOI
10.1038/leu.2013.166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Will the real myeloma please stand up?
- (2013) S Kumar et al. LEUKEMIA
- Have drug combinations supplanted stem cell transplantation in myeloma?
- (2012) A. Palumbo et al. BLOOD
- Consolidation therapy in myeloma: a consolidated approach?
- (2012) J. F. San-Miguel BLOOD
- Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
- (2012) P. L. Bergsagel et al. BLOOD
- Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
- (2012) L. Rosinol et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
- (2012) B Paiva et al. LEUKEMIA
- High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
- (2012) G Bianchi et al. LEUKEMIA
- Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS
- (2012) J A Katzmann et al. LEUKEMIA
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- Exome sequencing in tracking clonal evolution in multiple myeloma following therapy
- (2012) N Weston-Bell et al. LEUKEMIA
- EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
- (2012) T Kalina et al. LEUKEMIA
- Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma
- (2012) J T Larsen et al. LEUKEMIA
- Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?
- (2012) S Z Usmani et al. LEUKEMIA
- Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
- (2012) E Kastritis et al. LEUKEMIA
- Lenalidomide in Myeloma — A High-Maintenance Friend
- (2012) Ashraf Z. Badros NEW ENGLAND JOURNAL OF MEDICINE
- Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management
- (2011) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
- (2011) J. Martinez-Lopez et al. BLOOD
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
- (2011) M. Dimopoulos et al. BLOOD
- Can multiple myeloma become a curable disease?
- (2011) J. F. San-Miguel et al. HAEMATOLOGICA
- Diagnosis of Smoldering Multiple Myeloma
- (2011) S. Vincent Rajkumar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Importance of Achieving a Complete Response in Multiple Myeloma, and the Impact of Novel Agents
- (2010) Asher A. Chanan-Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of Autotransplantation Trials for Multiple Myeloma: Update of Protocols Conducted by the Intergroupe Francophone du Myelome, Southwest Oncology Group, and University of Arkansas for Medical Sciences
- (2010) Bart Barlogie et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
- (2010) Jens Hillengass et al. JOURNAL OF CLINICAL ONCOLOGY
- Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping
- (2010) E S Costa et al. LEUKEMIA
- How I treat multiple myeloma in younger patients
- (2009) A. K. Stewart et al. BLOOD
- The role of complete response in multiple myeloma
- (2009) J.-L. Harousseau et al. BLOOD
- Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma
- (2008) Bart Barlogie et al. CANCER
- Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
- (2008) Juan José Lahuerta et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
- (2007) A. Dispenzieri et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started